{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    23,
    26,
    27,
    28,
    36,
    37,
    55,
    56
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "SEL Investigator’s Brochure Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.2.1",
        "sectionTitle": "General Information for SEL",
        "description": "Reference to the SEL Investigator’s Brochure (IB) for additional details."
      },
      {
        "id": "ref_2",
        "name": "GS-0976 IB Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.3.1",
        "sectionTitle": "General Information for GS-0976",
        "description": "Reference to the GS-0976 Investigator’s Brochure (IB) for additional details."
      },
      {
        "id": "ref_3",
        "name": "GS-9674 IB Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.4.1",
        "sectionTitle": "General Information for GS-9674",
        "description": "Reference to the GS-9674 Investigator’s Brochure (IB) for additional details."
      },
      {
        "id": "ref_4",
        "name": "Hypertriglyceridemia Algorithm Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.7",
        "sectionTitle": "Risk/Benefit Assessment for the Study",
        "description": "Reference to Figure 7-3 for mitigation strategies for triglyceride elevations."
      },
      {
        "id": "ref_5",
        "name": "Pruritus Management Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.7",
        "sectionTitle": "Risk/Benefit Assessment for the Study",
        "description": "Reference to Section 7.5.5 for pruritus treatment initiation."
      },
      {
        "id": "ref_6",
        "name": "Hepatotoxicity Risk Mitigation Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.7",
        "sectionTitle": "Risk/Benefit Assessment for the Study",
        "description": "Reference to Section 7.5 for discontinuation parameters due to liver test abnormalities."
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "List of Representative Disallowed and Use with Caution Medications",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table 5-1",
        "pageNumber": 5
      },
      {
        "id": "annot_2",
        "text": "The information contained in this document... is provided to you in confidence as an investigator... You will not disclose any of the information to others without written authorization.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "CONFIDENTIALITY STATEMENT",
        "pageNumber": 1
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "Original",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-01-08",
        "description": "Original Protocol",
        "amendmentNumber": "0"
      },
      {
        "id": "ver_2",
        "versionNumber": "Amendment 1",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-01-31",
        "description": "Protocol Amendment 1",
        "amendmentNumber": "1"
      },
      {
        "id": "ver_3",
        "versionNumber": "Amendment 2",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-02-22",
        "description": "Protocol Amendment 2",
        "amendmentNumber": "2"
      },
      {
        "id": "ver_4",
        "versionNumber": "Amendment 3",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-05-10",
        "description": "Protocol Amendment 3",
        "amendmentNumber": "3"
      },
      {
        "id": "ver_5",
        "versionNumber": "4.0",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2019-04-25",
        "description": "Current active version of the protocol",
        "amendmentNumber": "Amendment 4"
      }
    ],
    "summary": {
      "referenceCount": 6,
      "annotationCount": 2,
      "versionCount": 5
    }
  }
}